# Viability Summary Dashboard: [Project Name]

**Project**: [Project Name]
**Date**: [YYYY-MM-DD]
**Products Evaluated**: [Number]
**Assessment Phase**: Viability (Step 12 - Business Model Evaluation)

---

## Executive Summary

[2-3 sentences summarizing the viability assessment scope, number of products defined, and overall viability status]

---

## Product Portfolio Overview

### Product Configurations

| Product Name | Target Client | Requesters | MVP Features | Revenue Model | Status |
|-------------|--------------|------------|--------------|---------------|---------|
| [Product 1] | [Client segment] | [Count] | [Count] | [Type - e.g., Subscription] | [Ready/Needs work/Blocked] |
| [Product 2] | [Client segment] | [Count] | [Count] | [Type] | [Status] |
| [Product 3] | [Client segment] | [Count] | [Count] | [Type] | [Status] |

**Portfolio Summary**:
- Total products defined: [Number]
- Total client segments served: [Number]
- Total MVP features across portfolio: [Number unique features]
- Primary revenue models: [List unique models]

---

## Strategic Positioning Matrix

### Product-Client Fit

| Product | Primary Value Prop | Client Segment | Competitive Position | Market Entry Strategy |
|---------|-------------------|----------------|---------------------|----------------------|
| [Product 1] | [Core positioning in 5-7 words] | [Client] | [Strong/Moderate/Emerging] | [Direct/Partnership/Hybrid] |
| [Product 2] | [Core positioning] | [Client] | [Position] | [Strategy] |
| [Product 3] | [Core positioning] | [Client] | [Position] | [Strategy] |

---

## Need Coverage Analysis

### Fundamental Needs Addressed Across Portfolio

Table showing which products address which fundamental needs:

| # | Fundamental Need | Intensity | Product 1 | Product 2 | Product 3 | Coverage Status |
|---|-----------------|-----------|-----------|-----------|-----------|-----------------|
| 1 | [Need statement] | Fundamental | ✓ MVP | ✓ Phased | — | Covered |
| 2 | [Need statement] | Fundamental | ✓ MVP | ✓ MVP | ✓ MVP | Strong |
| 3 | [Need statement] | Fundamental | — | — | ✓ MVP | Single product |
| 4 | [Need statement] | Fundamental | ✓ Phased | — | — | Partial |

**Coverage Metrics**:
- Total fundamental needs identified: [X]
- Covered by at least one product MVP: [Y] ([Y/X]%)
- Covered by multiple products: [Z]
- **Gaps**: [List any fundamental needs not addressed OR "None - all fundamental needs covered"]

---

### Important Needs Coverage

| # | Important Need | Product 1 | Product 2 | Product 3 | Coverage |
|---|---------------|-----------|-----------|-----------|----------|
| 1 | [Need statement] | ✓ MVP | ✓ MVP | — | Multiple |
| 2 | [Need statement] | ✓ Phased | — | ✓ MVP | Partial |
| 3 | [Need statement] | — | ✓ MVP | ✓ Phased | Moderate |

**Important Needs Summary**:
- Total important needs: [X]
- Covered by portfolio: [Y] ([%])
- Strategic coverage assessment: [Strong/Adequate/Gaps exist]

---

## Feature Comparison Matrix

### MVP Features Across Products

Table showing feature reuse and product-specific features:

| Feature Name | Product 1 | Product 2 | Product 3 | Validation | Timeline |
|--------------|-----------|-----------|-----------|------------|----------|
| [Shared feature 1] | ✓ MVP | ✓ MVP | — | >5 interviewed | Available |
| [Shared feature 2] | ✓ MVP | ✓ Phased | ✓ MVP | >5 interviewed | Short term |
| [Product 1 unique] | ✓ MVP | — | — | <5 interviewed | Available |
| [Product 2 unique] | — | ✓ MVP | — | >5 interviewed | Short term |
| [Product 3 unique] | — | — | ✓ MVP | >5 interviewed | Available |

**Feature Portfolio Metrics**:
- Total unique features across all products: [Count]
- Features used in multiple products (shared): [Count]
- Product-specific features: [Count]
- MVP features with >5 interviews: [Count]/[Total] = [%]

**Feature Development Efficiency**:
- [X]% of features are reused across products (development leverage)
- [Y] features require shared infrastructure (platform benefits)
- [Z] product-specific features justify separate configurations

---

## Business Model Comparison

### Revenue Models

| Product | Pricing Approach | Revenue Type | Primary Mechanism | Target Annual Revenue |
|---------|-----------------|--------------|-------------------|----------------------|
| [Product 1] | [Subscription] | Recurring | [e.g., $49/month per user] | [e.g., $500K at 850 users] |
| [Product 2] | [Transaction] | Recurring | [e.g., 10% commission] | [e.g., $300K on $3M GMV] |
| [Product 3] | [License] | One-time + Support | [e.g., $5K + $1K annual] | [e.g., $200K from 40 clients] |

**Revenue Model Assessment**:
- Primary revenue type: [Recurring | One-time | Mixed]
- Model diversity: [All similar | Complementary mix | Varied]
- Coherence: [Models align strategically | Independent | Potential conflicts]

---

### Distribution Strategies

| Product | Primary Discovery | Primary Purchase | Intermediaries | CAC Estimate |
|---------|------------------|------------------|----------------|--------------|
| [Product 1] | [SEO, content] | Direct web | None (Direct) | [Low/Med/High] |
| [Product 2] | [Sales team] | Direct sales | Partners (15%) | [Low/Med/High] |
| [Product 3] | [Referrals] | Marketplace | Platform fees | [Low/Med/High] |

**Distribution Assessment**:
- **Shared channels**: [List any channels used by multiple products]
- **Channel conflicts**: [Any competition or conflict | None identified]
- **Resource efficiency**: [High leverage | Moderate | Each product requires dedicated resources]

---

### Cost Structure Patterns

| Product | Fixed Costs | Variable Costs | Primary Cost Driver | Margin Potential |
|---------|-------------|----------------|---------------------|------------------|
| [Product 1] | [High/Med/Low] - [Main items] | [High/Med/Low] - [Main items] | [Customer count] | [High/Med/Low] |
| [Product 2] | [Level] - [Items] | [Level] - [Items] | [Transaction volume] | [Potential] |
| [Product 3] | [Level] - [Items] | [Level] - [Items] | [Geographic expansion] | [Potential] |

**Cost Structure Insights**:
- **Shared costs**: [Development platform | Core team | Infrastructure] (portfolio efficiency)
- **Product-specific costs**: [Sales for P2 | Content for P1 | Partnerships for P3]
- **Scaling efficiency**: [Platform scales well | Linear scaling | Volume-dependent]

---

## Resource Requirements Summary

### Shared Resources (Cross-Product)

**Development & Technology**:
- [Resource 1 used by multiple products - e.g., "Core platform architecture"]
- [Resource 2 - e.g., "Mobile app development team (serves Product 1 & 2)"]
- [Resource 3 - e.g., "Cloud infrastructure"]

**Human Resources**:
- [Shared team - e.g., "Founders + 2 core developers"]
- [Shared capability - e.g., "Customer support team (handles all products)"]

**Partnerships**:
- [Shared partnership - e.g., "Payment processing (all products)"]
- [Shared partnership - e.g., "University research partnership (credibility for all)"]

**Efficiency Insight**: [X]% of resources are shared across products (capital efficiency benefit)

---

### Product-Specific Resources

#### Product 1: [Product Name]

**Unique Means**:
- [Resource specific to Product 1]
- [Resource specific to Product 1]

**Unique Partnerships**:
- [Partner specific to Product 1 - e.g., "Senior care association for B2B distribution"]

---

#### Product 2: [Product Name]

**Unique Means**:
- [Resource specific to Product 2]

**Unique Partnerships**:
- [Partner specific to Product 2]

---

#### Product 3: [Product Name]

**Unique Means**:
- [Resource specific to Product 3]

**Unique Partnerships**:
- [Partner specific to Product 3]

---

### Critical Partnerships

Dependencies that affect multiple products or are high-risk:

| Partner | Role/Contribution | Products Affected | Status | Risk Level |
|---------|-------------------|-------------------|---------|------------|
| [Partner 1] | [What they provide] | [Product 1, 2] | [Secured/High confidence/Uncertain] | [High/Med/Low] |
| [Partner 2] | [Contribution] | [Product 3] | [Status] | [Risk] |

**Partnership Assessment**:
- **Secured**: [Count] partnerships confirmed
- **High confidence**: [Count] partnerships in discussion
- **Uncertain**: [Count] partnerships assumed but not validated
- **Critical path**: [Partner name] must be secured for [Product X] viability

---

### Resource Gaps

Portfolio-level gaps affecting viability:

| Gap | Impact | Products Affected | Mitigation Strategy | Priority |
|-----|--------|-------------------|---------------------|----------|
| [Gap 1 - e.g., "24/7 support capacity"] | [Cannot deliver on promise] | [Product 1, 2] | [Phase to "responsive support" initially] | [High/Med/Low] |
| [Gap 2 - e.g., "Regulatory clearance"] | [Limits clinical claims] | [Product 1] | [Engage consultant Q1, soft launch without claims] | [Priority] |

**Gap Mitigation Status**: [[X]/[Total] gaps have mitigation strategies in place]

---

## Validation Status Portfolio View

### Information Reliability by Product

| Product | MVP Features | >5 Interviewed | <5 Interviewed | Not Interviewed | Reliability Rating |
|---------|--------------|----------------|----------------|-----------------|-------------------|
| Product 1 | [Count] | [X] features ([%]) | [Y] features | [Z] features | [Strong/Moderate/Weak] |
| Product 2 | [Count] | [X] features ([%]) | [Y] features | [Z] features | [Rating] |
| Product 3 | [Count] | [X] features ([%]) | [Y] features | [Z] features | [Rating] |

**Overall Portfolio Reliability**: [Strong | Moderate | Weak]

**Assessment**: [1-2 sentences on overall validation strength and any concerns]

---

### Business Model Coherence by Product

| Product | Value-Features | Value-Revenue | Revenue-Distribution | Distribution-Costs | Costs-Revenue | Overall |
|---------|---------------|---------------|---------------------|-------------------|---------------|---------|
| Product 1 | ✓ Aligned | ✓ Aligned | ✓ Aligned | ⚠️ Minor gap | ✓ Aligned | Coherent |
| Product 2 | ✓ Aligned | ✓ Aligned | ✓ Aligned | ✓ Aligned | ⚠️ Minor gap | Minor issues |
| Product 3 | ✓ Aligned | ⚠️ Gap | ✓ Aligned | ✓ Aligned | ✓ Aligned | Minor issues |

**Portfolio Business Model Health**: [All coherent | Mostly coherent with minor issues | Significant concerns]

**Issues to Address**: [List any business model incoherence or concerns]

---

## Key Insights

### Strengths (Portfolio-Level)

1. **[Strength 1 - tied to data]**
   - Evidence: [Specific validation data]
   - Impact: [Why this matters for viability]

2. **[Strength 2]**
   - Evidence: [Data]
   - Impact: [Implication]

3. **[Strength 3]**
   - Evidence: [Data]
   - Impact: [Implication]

---

### Opportunities

1. **[Opportunity 1]**
   - Description: [What the opportunity is]
   - Products affected: [Which products benefit]
   - Potential impact: [Revenue/margin/market share implications]

2. **[Opportunity 2]**
   - Description: [Opportunity]
   - Products affected: [Products]
   - Potential impact: [Impact]

---

### Concerns & Risks

#### Concern 1: [Title]

**Description**: [What the concern is]

**Products Affected**: [Which products]

**Impact**: [High/Medium/Low] - [Why this matters]

**Mitigation**: [Strategy to address]

**Status**: [Mitigated/In progress/Not yet addressed]

---

#### Concern 2: [Title]

**Description**: [Concern]

**Products Affected**: [Products]

**Impact**: [Level] - [Why]

**Mitigation**: [Strategy]

**Status**: [Status]

---

[Continue for 3-5 total concerns]

---

### Strategic Recommendations

#### Recommendation 1: [Action]

**Rationale**: [Why this is recommended]

**Products Impacted**: [Which products]

**Priority**: [High/Medium/Low]

**Timeframe**: [Immediate/Short-term/Long-term]

**Owner**: [Who should lead this]

---

#### Recommendation 2: [Action]

**Rationale**: [Why]

**Products Impacted**: [Products]

**Priority**: [Level]

**Timeframe**: [When]

**Owner**: [Who]

---

[Continue for 3-5 recommendations]

---

## Prioritization Guidance

### Product Launch Sequencing

**Recommended Launch Order**:

**Phase 1**: [Product name]
- **Rationale**: [Why launch first - e.g., strongest validation, simplest to build, fastest to revenue]
- **Timeline**: [Timeframe]
- **Success Criteria**: [What defines successful launch]

**Phase 2**: [Product name]
- **Rationale**: [Why second - e.g., builds on Phase 1 learnings, requires Phase 1 infrastructure]
- **Timeline**: [Timeframe]
- **Dependencies**: [What must be in place from Phase 1]

**Phase 3**: [Product name]
- **Rationale**: [Why third - e.g., most complex, requires market maturity, optional enhancement]
- **Timeline**: [Timeframe]
- **Dependencies**: [Prerequisites]

**Alternative Consideration**: [Any rationale for different sequencing]

---

### Resource Allocation Priorities

**Development Resources**:
1. [Priority 1 - e.g., "Core platform features (shared by all products)"] - [% allocation]
2. [Priority 2 - e.g., "Product 1 MVP features"] - [% allocation]
3. [Priority 3] - [% allocation]

**Marketing/Sales Resources**:
1. [Priority 1 - e.g., "Product 1 customer acquisition"] - [% allocation]
2. [Priority 2] - [% allocation]

**Partnership Development**:
1. [Priority 1 - e.g., "Secure Partner X (critical for Product 1)"] - Timeline: [Date]
2. [Priority 2] - Timeline: [Date]

---

## Next Steps

### Immediate Actions (This Sprint)

| Action | Owner | Due Date | Products Affected | Success Criteria |
|--------|-------|----------|-------------------|------------------|
| [Action 1 - e.g., "Validate $49 pricing with 10 customers"] | [Name] | [Date] | [Product 1] | [Criteria] |
| [Action 2] | [Name] | [Date] | [Products] | [Criteria] |
| [Action 3] | [Name] | [Date] | [Products] | [Criteria] |

---

### Short-Term Priorities (1-3 Months)

| Priority | Description | Owner | Target Date | Success Metrics |
|----------|-------------|-------|-------------|-----------------|
| 1 | [Priority action 1] | [Name] | [Date] | [Metric] |
| 2 | [Priority action 2] | [Name] | [Date] | [Metric] |
| 3 | [Priority action 3] | [Name] | [Date] | [Metric] |

---

### Long-Term Considerations (3-12 Months)

1. **[Consideration 1]**
   - Description: [What to consider]
   - Timing: [When to address]
   - Dependencies: [What must happen first]

2. **[Consideration 2]**
   - Description: [What to consider]
   - Timing: [When]
   - Dependencies: [Prerequisites]

---

## Gaps & Assumptions Log

### Information Gaps

| Gap | Products Affected | Impact on Viability | Validation Plan | Target Date |
|-----|-------------------|---------------------|-----------------|-------------|
| [Gap 1 - e.g., "Actual willingness to pay for Product 1"] | [Product 1] | [High - pricing unvalidated] | [Price testing with 20 prospects] | [Date] |
| [Gap 2] | [Products] | [Impact level] | [Plan] | [Date] |

---

### Key Assumptions

| Assumption | Products Affected | Risk if Wrong | Validation Approach |
|------------|-------------------|---------------|---------------------|
| [Assumption 1 - e.g., "Seniors will adopt digital solution"] | [Product 1] | [High - entire model fails] | [Pilot with 50 users, track adoption rate] |
| [Assumption 2] | [Products] | [Risk level] | [Validation] |

---

## Financial Modeling Prerequisites

**Ready for Financial Modeling**: [Yes/No/Partial]

**Prerequisites Status**:
- [ ] Revenue models defined with concrete mechanisms ✓
- [ ] Cost categories identified with fixed/variable split ✓
- [ ] Distribution CAC assumptions documented ✓
- [ ] Pricing validated or ranges established ✓
- [ ] Churn/retention assumptions noted ✓
- [ ] Timeline for market entry estimated ✓

**Inputs for Financial Model**:
- Revenue streams: [List with mechanisms]
- Cost drivers: [List with scaling assumptions]
- Customer acquisition: [CAC estimates or ranges]
- Retention: [Churn assumptions]
- Pricing: [Validated prices or ranges to model]

---

## Viability Score Indicators

*Preliminary assessment - formal scoring in overall Vianeo evaluation*

### Product-Level Viability Indicators

| Product | PMF Strength | Business Model Coherence | Resource Readiness | Validation Quality | Preliminary Rating |
|---------|--------------|-------------------------|-------------------|-------------------|-------------------|
| Product 1 | [Strong/Moderate/Weak] | [Coherent/Minor issues/Major issues] | [Ready/Gaps noted/Significant gaps] | [Strong/Moderate/Weak] | [4-5 Strong / 3-3.5 Moderate / 1-2.5 Weak] |
| Product 2 | [Rating] | [Status] | [Status] | [Quality] | [Rating] |
| Product 3 | [Rating] | [Status] | [Status] | [Quality] | [Rating] |

### Overall Portfolio Viability

**Viability Dimension (20% of Vianeo Score)**:

**Preliminary Assessment**: [4.0-5.0 Strong | 3.0-3.9 Moderate | 1.0-2.9 Weak]

**Rationale** (2-3 sentences):
[Explain overall viability assessment based on business model coherence, commercial sustainability, value proposition strength, market access feasibility, and MVP viability]

---

## Document Metadata

**Based On**:
- Product/Market Fit Definitions: [List products]
- Business Model Canvases: [List products]
- Desirability Analysis: Steps 5-7
- Feasibility Analysis: Step 11
- Ecosystem Analysis: Steps 8-9

**Feeds Into**:
- Financial Modeling: Step 13 (Revenue projections, Cost models, P&L, Cash flow)
- Go-to-Market Strategy: Distribution execution, Launch planning
- Product Development Roadmap: MVP prioritization, Feature phasing
- Investment Decision: Committee evaluation, Funding recommendations

**Document Status**: [Draft | Review | Final]

**Prepared By**: [Name]
**Reviewed By**: [Name if applicable]
**Approved By**: [Name if applicable]
**Date**: [YYYY-MM-DD]
**Version**: 1.0

---

**END OF VIABILITY SUMMARY DASHBOARD**
